Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Clin Ther. 2015 Jan 22;37(3):597–609. doi: 10.1016/j.clinthera.2014.12.011

Table 3.

Effects of Part D on Antidepressant Use among Dual Enrollees with Diabetes and Co-Morbid Major Depression by Drug Cap Status, Age and Race

Proportion with any Use Standardized Monthly Dose
CAP STATES Non-Elderly Level Change in the % with Any Use (%) % with Any Use Pre Part D (Nov 2005) % with Any Use 12 Mos Post Part D (Jan 2007) Level Change in SMDs per Month Mean SMDs Pre Part D Mean SMD 12 Mos Post Part D
 Whites 0.08 (0.06,0.11)a 21.5% 31.8% 0.12 (0.09,0.15)a 0.49 0.62
 Blacks 0.04 (0.002,0.01)a 13.9% 17.7% 0.05 (0.01,0.09)b 0.24 0.29
 Difference 0.04 (0.01,0.08)b 0.10 (0.03,0.16)a
Elderly
 Whites 0.03 (0.02,0.04)a 10.4% 15.0% 0.03 (0.0002,0.06)b 0.16 0.20
 Blacks 0.04 (0.03,0.04)a 6.7% 10.9% 0.03 (0.02,0.03)a 0.08 0.12
 Difference −0.01 (−0.02,0.003) 0.004 (−0.03, 0.04)
NO CAP STATES Non-Elderly
 Whites −0.01 (−0.02, −0.004) 43.6% 42.8% 0.004 (−0.03,0.03) 0.87 0.87
 Blacks 0.01 (−0.0004,0.03) 23.1% 23.2% 0.02 (−0.01,0.05) 0.42 0.42
 Difference −0.02 (−0.03, −0.01)a −0.01 (−0.04, 0.01)
Elderly
 Whites −0.01 (−0.02,0.001) 25.0% 24.7% −0.001 (−0.002,0.00001) 0.34 0.34
 Blacks −0.01 (−0.02, −0.01) 12.6% 11.8% −0.02 (−0.04, −0.01)a 0.15 0.14
 Difference 0.01 (−0.003, 0.02) 0.01 (−0.01, 0.04)
a

p<0.01

b

p<0.05